Alemtuzumab/cladribineAutoimmune thyroid disorder and alopecia areata universalis: 2 case reports

被引:0
|
作者
机构
关键词
D O I
10.1007/s40278-022-11622-9
中图分类号
学科分类号
摘要
引用
收藏
页码:29 / 29
相关论文
共 50 条
  • [1] Alopecia areata universalis, other autoimmune adverse event related to alemtuzumab
    Carcamo, Claudia
    Ciampi, Ethel
    Mosso, Lorena
    Jorge Manriquez, Juan
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 (01) : 167 - 168
  • [2] Case of alopecia universalis associated with alemtuzumab treatment in MS
    Leussink, Verena Isabell
    Reifenberger, Julia
    Hartung, Hans-Peter
    NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2018, 5 (03):
  • [3] Topical 2% tofacitinib for children with alopecia areata, alopecia totalis, and alopecia universalis
    Putterman, Elana
    Castelo-Soccio, Leslie
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 78 (06) : 1207 - +
  • [4] Successful Treatment of an Alopecia areata partim universalis Case with Tofacitinib
    Chapsa, M.
    Kuske, M.
    Aschoff, R.
    AKTUELLE DERMATOLOGIE, 2020, 46 (05) : 220 - 222
  • [5] Alemtuzumab for treating Patients with Alopecia areata - A Case Report
    Dikeoulia, E. E.
    Neufeld, M.
    Pawlitzki, M.
    Boehm, M.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2021, 19 : 38 - 38
  • [8] Effectiveness of Oral Tofacitinib Dose Tapering in a Case of Alopecia Areata Universalis
    Esteves, Mariana
    Lopes, Sofia
    Azevedo, Filomena
    Pedrosa, Ana
    SKIN APPENDAGE DISORDERS, 2021, 7 (01): : 36 - 40
  • [9] Case of alemtuzumab-related alopecia areata management in MS
    Chan, Jillian K.
    Traboulsee, Anthony L.
    Sayao, Ana-Luiza
    NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2019, 6 (01):
  • [10] Thyroid treatment of alopecia areata - Report of a case
    Gordon, MB
    ARCHIVES OF DERMATOLOGY AND SYPHILOLOGY, 1928, 17 (06): : 817 - 820